Compassionate Access, Research Expansion, and Respect States Act of 2015

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass amendments to various appropriations bills that would protect or benefit medical marijuana patients. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. The bill would allow banks acting in accordance with state marijuana laws to have access to banking services, as currently, state-legal marijuana businesses must operate in a "cash only" environment. It would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 1965 Maintaining dignity and Eliminating unnecessary Restrictive Confinement of Youths Act of 2015 HR 2823 Protecting Youth from Solitary Confinement Act HR 1013 Regulate Marijuana like Alcohol Act of 2015 HR 1153 Asylum Reform and Board Protection Act of 2015 S. 683 Compassionate Access, Research Expansion, and Respect States Act of 2015 HR 1538 Compassionate Access, Research Expansion, and Respect States Act of 2015

Client expense: $36,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. The bill would allow banks acting in accordance with state marijuana laws to have access to banking services, as currently, state-legal marijuana businesses must operate in a "cash only" environment. It would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass amendments to various appropriations bills that would protect or benefit medical marijuana patients. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research

Client expense: Not reported · Firm income: $20,000

Advocate for passage of the CARERS Act (S. 683).

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying in support of H.R. 1013 - Regulate Marijuana Like Alcohol Act. Lobbying in support of H.R. 1014 - Marijuana Tax Revenue Act of 2015. Lobbying in support of H.R. 1940 - Respect State Marijuana Laws. Lobbying in support of S. 2237 - Ending Federal Marijuana Prohibition Act of 2015. Lobbying in support of S. 683 and H.R. 1538 - Compassionate Access, Research Expansion, and Respect States Act of 2015 General issues related to the cannabis industry and the need for elected officials on Capitol Hill to represent their state by urging the Obama administration to allow states to establish and carry out their own laws related to cannabis.

Client expense: $102,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1965 Maintaining Dignity and Eliminating unnecessary Restrictive Confinement of Youths Act of 2015 HR 2823 Protecting Youth from Solitary Confinement Act HR 1013 Regulate Marijuana like Alcohol Act of 2015 HR 1153 Asylum Reform and Board Protection Act of 2015 S. 683 Compassionate Access, Research Expansion, and Respect States Act of 2015 HR 1538 Compassionate Access, Research Expansion, and Respect States Act of 2015

Client expense: $64,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying in support of H.R. 1013 - Regulate Marijuana Like Alcohol Act. Lobbying in support of H.R. 1014 - Marijuana Tax Revenue Act of 2015. Lobbying in support of H.R. 1940 - Respect State Marijuana Laws. Lobbying in support of S. 2237 - Ending Federal Marijuana Prohibition Act of 2015. Lobbying in support of S. 683 and H.R. 1538 - Compassionate Access, Research Expansion, and Respect States Act of 2015 General issues related to the cannabis industry and the need for elected officials on Capitol Hill to represent their state by urging the Obama administration to allow states to establish and carry out their own laws related to cannabis.

Client expense: $112,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for passage of the CARERS Act (S. 683).

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA and DEA regulation of cannabidiol; monitor S. 1333 (Therapeutic Hemp Medical Access Act of 2015), HR 1635 (Charlotte's Web Medical Access Act of 2015), S. 683/S. 1538 (Compassionate Access, Research Expansion and Respect States Act) and activity related to medical marijuana research

Client expense: Not reported · Firm income: Not reported

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. The bill would allow banks acting in accordance with state marijuana laws to have access to banking services, as currently, state-legal marijuana businesses must operate in a "cash only" environment. It would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass amendments to various appropriations bills that would protect or benefit medical marijuana patients. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. Worked to introduce and pass various appropriations amendments that would similarly protect or benefit medical marijuana patients.

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. The bill would allow banks acting in accordance with state marijuana laws to have access to banking services, as currently, state-legal marijuana businesses must operate in a "cash only" environment. It would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.R. 667 - the Veterans Equal Access Act. The language of this bill is contained within the CARERS Act and is supported by ASA.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 1965 Maintaining Dignity and Eliminating unnecessary Restrictive Confinement of Youths Act of 2015 HR 2823 Protecting Youth from Solitary Confinement Act HR 1013 Regulate Marijuana like Alcohol Act of 2015 HR 1153 Asylum Reform and Board Protection Act of 2015 S. 683 Compassionate Access, Research Expansion, and Respect States Act of 2015 HR 1538 Compassionate Access, Research Expansion, and Respect States Act of 2015

Client expense: $52,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to NIH funding S. 320: Medical Innovation Act of 2015 - Provisions related to National Institutes of Health (NIH) funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2016 - Provisions related to registration under the Controlled Substances Act (CSA) S. 524: Comprehensive Addiction and Recovery Act of 2016 - Provisions related to opioids S. 683: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 849: Advancing Research for Neurological Diseases Act of 2016 - Provisions related to research on neurological diseases S. 1128: Preserving Access to Orphan Drugs Act - Provisions related to orphan drug tax (113th Congress) S. 1455: Recovery Enhancement for Addiction Treatment Act - Provisions related to opioids S. 1597: Patient-Focused Impact Assessment Act of 2016 - Provisions related to patient-focused drug development S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2016 - Provisions related to improvements in the regulation of combination drug-device products S. 1878: Advancing Hope Act of 2016 - Provisions related to pediatric cancer and other pediatric diseases S. 2014: Next Generation Researchers Act - Provisions related to NIH promoting new research. S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016 - Provisions related to rare disease treatment S. 2055 - the Medical Countermeasure Innovation Act of 2015 S. 2256: Co-Prescribing Saves Lives Act of 2015 - Provisions related to co-prescribing S. 2388: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 - Provisions related to reciprocity of drug approvals S. 2503: Preventing Superbugs and Protecting Patients Act - Provisions related to antibiotic development S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act - Provisions related to priority review vouchers S. 2615: Increasing Competition in Pharmaceuticals Act - Provisions related to FDA review of generic drugs and study on risk evaluation and mitigation strategies (REMS) program S. 2624: National Biomedical Research Act - Provisions related to mandatory funding for NIH and FDA S. 2680: Mental Health Reform Act of 2016 - Provisions related to mental health issues S. 2689: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments S. 2700: FDA and NIH Workforce Modernization Act - Provisions related to FDA and NIH H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2745: Standard Merger and Acquisition Reviews Through Equal Rules Act of 2015; Motion to Recommit H.R. 2745 with Instructions - Provisions related to prescription drug costs H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing HR. 3299 - the Strengthening Public Health Emergency Response Act of 2015 H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3762: Restoring Americans Healthcare Freedom Reconciliation Act of 2015 - Provisions related to amending and withdrawing funding from the Affordable Care Act H.R. 4365: Protecting Patient Access to Emergency Medications Act of 2016 - Provisions related to controlled substances H.R. 4762: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments H.R. 4784: Lower Drug Costs Through Competition Act - Provisions related to generic drugs and priority review vouchers; REMS study; and tropical disease product applications The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act policy issues Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed rules [CMS-2390-P] Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy including sharing of truthful and non-misleading information about medicines with healthcare professionals Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biologics Price Competition and Innovation Act (BPCIA) implementation issues Generic Drug User Fee Act (GDUFA) policy issues Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Expedited drug approval policy issues Compassionate use policy issues Biosimilar approval and reimbursement policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker policy issues Policy issues related to prescription drug abuse and secure disposal Antibiotics development policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner Prescription drug importation policy issues Cancer Moonshot

Client expense: $1,490,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), Vice President of the U.S.

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to NIH funding S. 320: Medical Innovation Act of 2015 - Provisions related to National Institutes of Health (NIH) funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2016 - Provisions related to registration under the Controlled Substances Act (CSA) S. 524: Comprehensive Addiction and Recovery Act of 2016 - Provisions related to opioids S. 683: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 849: Advancing Research for Neurological Diseases Act of 2016 - Provisions related to research on neurological diseases S. 1128: Preserving Access to Orphan Drugs Act of 2013 - Provisions related to orphan drug tax (113th Congress) S. 1455: Recovery Enhancement for Addiction Treatment Act - Provisions related to opioids S. 1597: Patient-Focused Impact Assessment Act of 2016 - Provisions related to patient-focused drug development S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2016 - Provisions related to improvements in the regulation of combination drug-device products S. 1878: Advancing Hope Act of 2016 - Provisions related to pediatric cancer and other pediatric diseases S. 2014: Next Generation Researchers Act - Provisions related to NIH promoting new research. S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016 - Provisions related to rare disease treatment S. 2256: Co-Prescribing Saves Lives Act of 2015 - Provisions related to co-prescribing of opioids and reversal agents S. 2388: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 - Provisions related to reciprocity of drug approvals S. 2503: Preventing Superbugs and Protecting Patients Act - Provisions related to antibiotic development S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act - Provisions related to priority review vouchers S. 2615: Increasing Competition in Pharmaceuticals Act - Provisions related to FDA review of generic drugs and study on risk evaluation and mitigation strategies (REMS) program S. 2624: National Biomedical Research Act - Provisions related to mandatory funding for NIH and FDA S. 2680: Mental Health Reform Act of 2016 - Provisions related to mental health issues S. 2689: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments S. 2700: FDA and NIH Workforce Modernization Act - Provisions related to FDA and NIH H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2745: Standard Merger and Acquisition Reviews Through Equal Rules Act of 2015; Motion to Recommit H.R. 2745 with Instructions - Provisions related to prescription drug costs H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3762: Restoring Americans Healthcare Freedom Reconciliation Act of 2015 - Provisions related to amending and withdrawing funding from the Affordable Care Act H.R. 4365: Protecting Patient Access to Emergency Medications Act of 2016 - Provisions related to controlled substances H.R. 4762: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments H.R. 4784: Lower Drug Costs Through Competition Act - Provisions related to generic drugs and priority review vouchers; REMS study; and tropical disease product applications The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act policy issues Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed rules [CMS-2390-P] Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy including sharing of truthful and non-misleading information about medicines with healthcare professionals Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biologics Price Competition and Innovation Act (BPCIA) implementation issues Generic Drug User Fee Act (GDUFA) policy issues Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Expedited drug approval policy issues Compassionate use policy issues Biosimilar approval and reimbursement policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker policy issues Policy issues related to prescription drug abuse and secure disposal Antibiotics development policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner Prescription drug importation policy issues Cancer Moonshot

Client expense: $5,950,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), Vice President of the U.S.

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.R. 667 - the Veterans Equal Access Act. The language of this bill is contained within the CARERS Act and is supported by ASA.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. The bill would allow banks acting in accordance with state marijuana laws to have access to banking services, as currently, state-legal marijuana businesses must operate in a "cash only" environment. It would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

S. 683/H.R. 1538 - the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, a medical marijuana bill that would protect patients, doctors, and others acting in accordance with their state medical marijuana laws from federal prosecution and interference. Would also expand health research for marijuana-based therapy, allow for the interstate transportation of low-THC/CBD-rich derivations of marijuana, reschedule marijuana to Sch. II under the CSA, advance and allow VA doctors to recommend medical marijuana veteran patients if allowed by state law. H.Amdt.130 "Veterans Equal Access Amendment" to H.R. 2029, (offered by Senator Daines in full committee markup in the Senate). States, "None of the funds made available by this Act may be used to implement, administer, or enforce Veterans Health Administration directive 2011-004 (or directive of the same substance) with respect to the prohibition on "VA providers from completing forms seeking recommendations or opinions regarding a Veteran's participation in a State marijuana program"." H.Amdt.332 to H.R. 2578, (offered by Senator Mikulski in full committee markup in the Senate): Amendment prohibits the use of funds in the bill to supersede State law in those States that have legalized the use of medical marijuana. Merkley marijuana banking amendment to FY16 Financial Services & General Government Appropriations Bill (H.R.2995 in House). To prohibit funds from being used to prohibit or penalize financial institutions that provide financial services to a certain persons in States where marijuana is legal for recreational or medicinal purposes.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA)

Advocate for passage of the CAREERS Act (S. 683).

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1965 Maintaining dignity and Eliminating unnecessary Restrictive Confinement of Youths Act of 2015 HR 2823 Protecting Youth from Solitary Confinement Act HR 1013 Regulate Marijuana like Alcohol Act of 2015 HR 1153 Asylum Reform and Board Protection Act of 2015 S. 675 Record Expungement Designed to Enhance Employment Act of 2015 H.R. 1672 Record Expungement Designed to Enhance Employment Act of 2015 S. 683 Compassionate Access, Research Expansion, and Respect States Act of 2015 HR 1538 Compassionate Access, Research Expansion, and Respect States Act of 2015

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

S. 683 / HR 1538: CARERS Act of 2015 S. 988 / H.R. 2062: Protecting Student Athletes from Concussions Act of 2015 S. 1475 / H.R. 2603: Saving Lives, Saving Costs Act S. 1073: Stopping Improper Payments to Deceased People Act H.R. 6: 21st Century Cures Act, Title 1, and Sections 1122, & 3021 H.R. 1600: Patients' Access to Treatments Act of 2015 H.R. 1589: Ensuring Childrens Access to Specialty Care Act H.R. 2373: Legitimate Use of Medicinal Marijuana Act Maintenance/expansion of Graduate Medical Education (GME); NIH Funding.

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation: SJ ReS 19, Constitutional amendment to limit 1A on political speech-Issues Lobbied: First Amendment. S ReS 104, S ReS 104-Issues Lobbied: Border Prosecutions. S 217, Women's Health Protection Act-Issues Lobbied: Abortion Access. S 255, Fifth Amendment Integrity Restoration Act-Issues Lobbied: Civil Asset Forfeiture. S 356, Electronic Communications Privacy Amendments Act of 2015-Issues Lobbied: Privacy. S 439, Student Non-Discrimination Act of 2015-Issues Lobbied: LGBT Rights. S 456, Cyber Threat Sharing Act of 2015-Issues Lobbied: Cybersecurity. S 467, Corrections Act-Issues Lobbied: Detainers, Prison Early Release. S 497, Healthy Families Act-Issues Lobbied: Women's Rights. S 502, Smarter Sentencing Act-Issues Lobbied: Mandatory Minimums. S 512, Law Enforcement Access to Data Stored Abroad Act-Issues Lobbied: Privacy. S 607, Electronic Communications Privacy Act Amendments Act of 2013-Issues Lobbied: Privacy. S 675, Record Expungement Designed to Enhance Employment Act of 2015-Issues Lobbied: Criminal Records and Juvenile Solitary Confinement. S 683, CARERS Act of 2015-Issues Lobbied: Medical Marijuana. S 750, Arizona Borderlands Protection and Preservation Act-Issues Lobbied: Border Security. S 754, Cybersecurity Information Sharing Act of 2015-Issues Lobbied: Cybersecurity. S 786, FAMILY Act-Issues Lobbied: Women's Rights. S 877, Police CAMERA Act-Issues Lobbied: Body Worn Cameras. S 987, Free Flow of Information Act-Issues Lobbied: First Amendment. S 1056, End Racial Profiling Act (ERPA)-Issues Lobbied: Civil Rights, Criminal Justice, Racial Justice, Police Practices. S 1169, The Juvenile Justice and Delinquency Protection Reauthorization Act-Issues Lobbied: Civil Rights, Criminal Justice, Racial Justice, Juvenile Justice. S 1177, Every Child Achieves Act of 2015-Issues Lobbied: ESEA reauthorization, Education, School Discipline, School Climate, Sanctuary Cities, Detainers, Immigration Enforcement, LGBT Rights, Women's Rights, Criminal Justice. S 1376, National Defense Authorization Act-Issues Lobbied: Border security, Women's Rights. S 1382, Every Child Deserves a Family Act-Issues Lobbied: LGBT Rights. S 1512, Pregnant Workers Fairness Act-Issues Lobbied: Womens Rights. S 1513, Second Chance Act-Issues Lobbied: Criminal Justice. S 1553, Pain-Capable Unborn Child Protection Act-Issues Lobbied: Abortion Rights. S 1558, FY 2016 Defense Appropriations-Issues Lobbied: National Security, Guantanamo Bay, Indefinite Detention, Authorization for Use of Military Force. S 1590, Pregnancy Discrimination Amendment Act-Issues Lobbied: Women's Rights. S 1595, Protecting Individuals From Mass Aerial Surveillance Act of 2015-Issues Lobbied: Surveillance, Privacy. S 1598, First Amendment Defense Act-Issues Lobbied: LGBT Rights. S 1599, USA Freedom Act-Issues Lobbied: National Security. S 1619, FY 2016 Department of Homeland Security Appropriations-Issues Lobbied: National Security, Guantanamo Bay, Indefinite Detention, Authorization for Use of Military Force. S 1631, FISA Improvements Act-Issues Lobbied: National Security. S 1659, Voting Rights Advancement Act-Issues Lobbied: Voting Rights. S 1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016-Issues Lobbied: Religious Refusals/Womens Health Policy Riders. S 1762, Establishing Mandatory Minimums for Illegal Reentry Act-Issues Lobbied: Mandatory Minimums. S 1770, The Youth PROMISE Act-Issues Lobbied: Civil Rights, Criminal Justice, Racial Justice, Juvenile Justice. S 1788, The Safeguarding American Families from Exposure by Keeping Information and Data Secure (SAFE KIDS) Act-Issues Lobbied: Privacy. S 1812, Improving Cooperation with State and Local Governments and Preventing the Catch and Release of Criminal Aliens Act of 2015-Issues Lobbied: Sanctuary Cities, Detainers, Immigration Enforcement, Mandatory Minimums. S 1814, Stop Sanctuary Cities Act-Issues Lobbied: Sanctuary Cities, Detainers, Immigration Enforcement. S 1842, Protecting American Lives Act-Issues Lobbied: Sanctuary Cities, Detainers, Immigration Enforcement. S 1858, Equality Act-Issues Lobbied: LGBT Rights, Womens Rights, Reproductive Freedom, Racial Justice. S 1881, A bill to prohibit Federal funding of Planned Parenthood Federation of America-Issues Lobbied: Planned Parenthood Defunding. S 1910, The Financial Services and General Government FY16 Appropriations bill-Issues Lobbied: Religious Refusals/Womens Health Policy Riders, DHS budget: CBP/ICE Oversight and Accountability, Deferred Action. S 1965, MERCY Act-Issues Lobbied: Juvenile Solitary. S 2021, Fair Chance Act-Issues Lobbied: Criminal Justice Reform. S 2048, USA FREEDOM Act of 2015-Issues Lobbied: Surveillance. S 2146, Stop Sanctuary Policies and Protect Americans Act-Issues Lobbied: Detainers. S 2168, Law Enforcement Trust and Integrity Act-Issues Lobbied: Law Enforcement Reform. S 2536, SAVE Act-Issues Lobbied: First Amendment. S 2588, Cybersecurity Information Sharing Act-Issues Lobbied: Cybersecurity. HR5, Student Success Act-Issues Lobbied: Elementary and Secondary Act (ESEA) Reauthorization, Education, School Discipline, School Climate, Religious Liberty, Religion and Public Schools, Criminal Justice. HR6, 21st Century Cures Act-Issues Lobbied: Abortion Rights. HR22, DRIVE Act-Issues Lobbied: Hair Drug Testing. HR36, Pain-Capable Unborn Child Protection Act-Issues Lobbied: Abortion Restriction. HR148, DISCLOSE Act-Issues Lobbied: Campaign Finance Reform. HR234, Cyber Intelligence Sharing and Protection Act of 2015-Issues Lobbied: Cybersecurity. HR283, Electronic Communications Privacy Amendments Act of 2015-Issues Lobbied: Privacy. HR540, Fifth Amendment Integrity Restoration Act-Issues Lobbied: Civil Asset Forfeiture. HR637, Preserving American Privacy Act of 2013-Issues Lobbied: Privacy. HR719, Continuing resolution - FY 2016 appropriations-Issues Lobbied: Religious Refusals, Womens Health Policy Riders, Reproductive Rights. HR846, Student Non-Discrimination Act of 2015-Issues Lobbied: LGBT Rights. HR920, Smarter Sentencing Act-Issues Lobbied: Mandatory Minimums. HR932, Healthy Families Act-Issues Lobbied: Women's Rights. HR940, Health Care Conscience Rights Act-Issues Lobbied: Reproductive Rights & Religion and Belief. HR983, Online Communications and Geolocation Protection Act-Issues Lobbied: Privacy. HR1232, Stop Militarizing Law Enforcement Act-Issues Lobbied: Law Enforcement Militarization. HR1439, FAMILY Act-Issues Lobbied: Women's Rights. HR 1672, REDEEM Act-Issues Lobbied: Criminal Justice. HR1680, Police CAMERA Act-Issues Lobbied: Body Worn Cameras. HR1735, FY 2016 National Defense Authorization Act-Issues Lobbied: National Security, Guantanamo Bay, Indefinite Detention, Authorization for Use of Military Force, Torture, Law Enforcement Militarization, Women's Rights. HR1933, End Racial Profiling Act (ERPA)-Issues Lobbied: Civil Rights, Criminal Justice, Racial Justice, Police Practices. HR1962, Free Flow of Information Act-Issues Lobbied: First Amendment. HR2029, FY 2016 Military Construction, Veterans Affairs, and Related Agencies Appropriations-Issues Lobbied: National Security, Guantanamo Bay, Indefinite Detention. HR2048, USA Freedom Act 2015-Issues Lobbied: Surveillance. HR2092, Student Digital Privacy and Parental Rights Act of 2015-Issues Lobbied: Privacy. HR2197, The Youth PROMISE Act-Issues Lobbied: Civil Rights, Criminal Justice, Racial Justice, Juvenile Justice. HR 2421, REAL Act-Issues Lobbied: Criminal Justice. HR2449, Every Child Deserves a Family Act-Issues Lobbied: LGBT Rights. HR2530, Friendly Airports for Mothers Act of 2015-Issues Lobbied: Womens Rights. HR2578, CJS Appropriations Act-Issues Lobbied: Criminal Justice, Surveillance, Privacy, Immigration. HR2596, FY 2016 Intelligence Authorization Act-Issues Lobbied: Guantanamo Bay, Indefinite Detention, National Security, Surveillance. HR2646, Helping Families in Mental Health Crisis Act-Issues Lobbied: Disability Rights, Access to Justice, Privacy Rights. HR 2654, Pregnant Workers Fairness Act-Issues Lobbied: Women's Rights. HR2685, FY 2016 Defense Appropriations-Issues Lobbied: National Security, Guantanamo Bay, Indefinite Detention, Authorization for Use of Military Force, Torture. HR2772, FY 2016 State, Foreign Operations, and Related Programs Appropriations-Issues Lobbied: National Security. HR2800, Pregnancy Discrimination Amendment Act-Issues Lobbied: Women's Rights. HR2802, First Amendment Defense Act-Issues Lobbied: LGBT Rights. HR2867, Voting Rights Advancement Act-Issues Lobbied: Voting Rights. HR2875, Law Enforcement Trust and Integrity Act-Issues Lobbied: Law Enforcement Reform. HR2899, Countering Violent Extremism Act of 2015-Issues Lobbied: Racial Profiling, Countering Violent Extremism, National Security. HR2944, SAFE Justice Act-Issues Lobbied: Mandatory Minimums, Drug Reform, Sentencing. HR2972, Equal Access to Abortion Coverage in Health Insurance (EACH) Woman Act-Issues Lobbied: Reproductive Rights, Women's Rights. HR2995, The Financial Services and General Government FY16 Appropriations bill-Issues Lobbied: Religious Refusals, Womens Health Policy Riders. HR3009, Enforce the Law for Sanctuary Cities Act-Issues Lobbied: Detainers, "Sanctuary" Cities, Immigration Enforcement. HR 3011, Establishing Mandatory Minimums for Illegal Reentry Act-Issues Lobbied: Mandatory Minimums. HR3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016-Issues Lobbied: Religious Refusals, Womens Health Policy Riders. HR3128, Department of Homeland Security Appropriations Act-Issues Lobbied: DHS Budget: CBP/ICE Oversight and Accountability, Deferred Action. HR3134, Defund Planned Parenthood Act of 2015-Issues Lobbied: Planned Parenthood Defunding. HR3157, Student Privacy Protection Act-Issues Lobbied: Privacy. HR3158, RAISE Act-Issues Lobbied: Juvenile Justice. HR3185, Equality Act-Issues Lobbied: LGBT Rights, Womens Rights, Reproductive Freedom, Racial Justice. HR 3361, USA Freedom Act-Issues Lobbied: National Security. HR3470, Fair Chance Act-Issues Lobbied: Criminal Justice Reform. HR3495, Womens Public Health and Safety Act-Issues Lobbied: Medicaid Restrictions/Planned Parenthood Defunding. HR3504, Born-Alive Abortion Survivors Protection Act-Issues Lobbied: Abortion Restrictions. HR3518, Stop Civil Asset Forfeiture Funding for Marijuana Suppression Act-Issues Lobbied: Civil Asset Forfeiture. HR3576, Border Enforcement Accountability, Oversight and Community Engagement Act of 2015-Issues Lobbied: CBP Oversight and Accountability. HR3586, Border and Maritime Coordination Improvement Act-Issues Lobbied: Border Security. HR4225, SAVE Act-Issues Lobbied: First Amendment. HR 4291, FISA Transparency & Modernization Act-Issues Lobbied: National Security. HR4752, To limit ability of FCC to reclassify broadband-Issues Lobbied: First Amendment. Congressional Issues without Bill Numbers: Weaponized Drone Bill-Issues Lobbied: Privacy. EO 12333 and Section 702 surveillance-Issues Lobbied: Surveillance. Domestic Drones-Issues Lobbied: Privacy. Location Tracking Devices, Stingrays-Issues Lobbied: Privacy, Surveillance. Encryption, government back doors-Issues Lobbied: Privacy Surveillance. Various photo dissemination laws-Issues Lobbied: First Amendment. Fair Donations for All Act-Issues Lobbied: First Amendment. National Cybersecurity Protection Advancement Act of 2015 [Discussion Draft]-Issues Lobbied: Cybersecurity. Campaign Finance Reform Measures and Constitutional Amendments-Issues Lobbied: Campaign Finance Reform. Broadband Adoption Act-Issues Lobbied: First Amendment. Follow the Money Act-Issues Lobbied: First Amendment. Force Multiplier Act-Issues Lobbied: Information Sharing. CORRECT Act-Issues Lobbied: First Amendment. June 2003 Guidance Regarding the Use of Race by Federal Law Enforcement Agencies-Issues Lobbied: Racial Profiling, Civil Rights, Criminal Justice, Racial Justice, Police Practices, Countering Violent Extremism, National Security. FY 2017 immigration appropriations (immigration detention, family detention, immigration enforcement, 287(g) program, PEP, Secure Communities)-Issues Lobbied: Immigration. Bond hearings, Prolonged detention-Issues Lobbied: Immigration. Family detention, Immigration detention, Treatment of refugee women and children/victims of violence-Issues Lobbied: Immigration. DHS immigration enforcement reform: Secure Communities; Priority Enforcement Program (PEP); detainers; sanctuary cities-Issues Lobbied: Immigration. Prison Rape Elimination Act of 2003-Issues Lobbied: Criminal Justice Reform. Civil Asset Forfeiture-Issues Lobbied: Law Enforcement Reform. Indigent Defense-Issues Lobbied: Criminal Justice Reform. Federal RFRA legislation-Issues Lobbied: Religious Liberty & Refusals. Women in Combat-Issues Lobbied: Women's Rights. Electronic Communications Privacy Act (ECPA)-Issues Lobbied: Internet Privacy. Countering Violent Extremism Legislation-Issues Lobbied: Racial Profiling, Religious Liberty. Mens Rea-Issues Lobbied: Criminal Justice Reform. Cuba Travel Ban-Issues Lobbied: National Security. Revenge Pornography Bill-Issues Lobbied: First Amendment. Juvenile Justice and Delinquency Prevention Act-Issues Lobbied: Juvenile Justice. Voting Rights-Issues Lobbied: Voting Rights. Planned Parenthood Defunding-Issues Lobbied: Abortion Rights. Planned Parenthood Bill of Attainder-Issues Lobbied: Abortion Rights. Department of Defense 1033 program-Issues Lobbied: Law Enforcement Militarization. Bureau of Prisons Oversight-Issues Lobbied: Criminal Justice Reform. Email Tracking-Issues Lobbied: Privacy. Sexual Education Funding-Issues Lobbied: Reproductive Rights. Stonewall Resolution-Issues Lobbied: LGBT Rights. FOIA Improvement Act-Issues Lobbied: Government Transparency. Hyde Amendment-Issues Lobbied: Abortion Rights. Agencies: Bureau of Justice Statistics-Issues Lobbied: Disability Rights, Death in Custody Reporting. Bureau of Prisons-Issues Lobbied: Re-entry, Residential Drug Treatment. Department of Defense-Issues Lobbied: EO 12333 and Section 702 Surveillance. Department of Education-Issues Lobbied: Every Child Achieves Act of 2015, Civil Rights Data Collection. Department of Health and Human Services-Issues Lobbied: Access to Emergency Contraception in IHS Facilities, Access to Contraception and Abortion Care in ORR, Interior and Border Enforcement, Unaccompanied Minors, Disability Rights, Conditioning Devices, 1557 Proposed Rule, Revised Recommendations for Reducing the Risk of HIV Transmission by Blood and Blood Products (Draft Guidance). Department of Homeland Security-Issues Lobbied: Interior and Border Enforcement, Unaccompanied Minors, End Racial Profiling Act (ERPA), June 2003 Guidance Regarding the Use of Race by Federal Law Enforcement Agencies, DHS Immigration Enforcement Reform: Secure Communities, Priority Enforcement Program (PEP), Detainers, Sanctuary Cities, Family Detention, Immigration Detention, Treatment of Refugee Women and Children/Victims of Violence, Bond Hearings, Prolonged Detention, Immigration Appropriations (Immigration Detention, Family Detention, Immigration Enforcement, 287(g) Program, PEP, Secure Communities), FOIA rule, REAL ID. Department of Housing and Urban Development-Issues Lobbied: Fair Housing, Affirmatively Furthering Fair Housing. Department of Justice-Issues Lobbied: Location Tracking Devices, Stingrays, EO 12333 and Section 702 Surveillance, Interior and Border Enforcement, Border Prosecutions, Unaccompanied Minors, The Juvenile Justice and Delinquency Prevention Reauthorization Act, End Racial Profiling Act (ERPA), June 2003 Guidance Regarding the Use of Race by Federal Law Enforcement Agencies, Disability Rights, Death in Custody Reporting, Family Detention, Immigration Detention, Treatment of Refugee Women and Children/Victims of Violence, Torture, Rendition Classification, Sentencing Reform, Gender Bias Policing, Militarization of Police, Law Enforcement Reform, LAPD Body Camera Funding, Rescission of the OLC Memo, Muslim-Free Zone Bans by Public Accommodations, 1557 Proposed Rule, Gender Biased Policing. Department of State-Issues Lobbied: Torture, Guananamo Bay. Department of Treasury-Issues Lobbied: IRS c4 Rulemaking. Director of National Intelligence-Issues Lobbied: EO 12333 and Section 702 Surveillance. Equal Employment Opportunity Commission-Issues Lobbied: Disability Rights, Employer Wellness Programs. Executive Office of the President-Issues Lobbied: Fair Chance Hiring/Felon Employment, OLC Religious Exemption Memo, Criminal Justice Reform, Planned Parenthood Funding, Voting Rights, Cell Site Simulators, Transparency, Family Detention, Universal Periodic Review, Whistleblower Bill and Snowden Petition, Digital Strategies, Encryption, Pope Visit, Houston Equal Rights Ordinance, Endangered Species Rule, Solitary Confinement. Federal Aviation Administration-Issues Lobbied: Domestic Drones. Federal Bureau of Investigation-Issues Lobbied: Encryption, Government Back Doors," Location Tracking Devices, Stingrays. Federal Communications Commission-Issues Lobbied: Open Internet Rule, IP Transition, E-Rate Rulemaking, Low Power FM Application Window, Media Ownership Rule, Lifeline Broadband. Food and Drug Administration-Issues Lobbied: Disability Rights, Conditioning Devices, Revised Recommendations for Reducing the Risk of HIV Transmission by Blood and Blood Products (Draft Guidance). Indian Health Service-Issues Lobbied: Access to Emergency Contraception in IHS Facilities. Internal Revenue Service-Issues Lobbied: IRS c4 Rulemaking. National Oceanic and Atmospheric Administration-Issues Lobbied: Right to Petition. National Security Agency-Issues Lobbied: EO 12333 and Section 702 Surveillance. Office of Management and Budget-Issues Lobbied: Religious Refusals, Womens Health Policy Riders to Appropriations Continuing Resolution, Health Care Conscience Rights Act, Immigration Funding (Immigration Detention, Family Detention, Immigration Enforcement, 287(g) Program, PEP, Secure Communities), REAL ID. Office of Justice Program-Issues Lobbied: The Juvenile Justice and Delinquency Prevention Reauthorization Act. Office of Juvenile Justice & Delinquency Prevention-Issues Lobbied: The Juvenile Justice and Delinquency Prevention Reauthorization Act. Office of the Vice President-Issues Lobbied: Gender Biased Policing. Transportation Security Administration-Issues Lobbied: June 2003 Guidance Regarding the Use of Race by Federal Law Enforcement Agencies. U.S. Census Bureau-Issues Lobbied: Residence Rule, Prison-Based Gerrymandering. U.S. Citizenship and Immigration Services-Issues Lobbied: Family Detention, Immigration Detention, Treatment of Refugee Women and Children/Victims of Violence. U.S. Customs and Border Protection-Issues Lobbied: Border Enforcement/CBP Oversight and Excessive Use of Force, June 2003 Guidance Regarding the Use of Race by Federal Law Enforcement Agencies. U.S. Fish and Wildlife Service-Issues Lobbied: Right to Petition. U.S. Immigration and Customs Enforcement-Issues Lobbied: Deportation and Detention Practices, DHS Immigration Enforcement Reform: Secure Communities, Priority Enforcement Program (PEP), Detainers, Sanctuary Cities, Family Detention, Immigration Detention, Treatment of Refugee Women and Children/Victims of Violence. United States Trade Representative-Issues Lobbied: Trans-Pacific Partnership. White House-Issues Lobbied: Religious Refusals, Womens Health Policy Riders to Appropriations Continuing Resolution, Health Care Conscience Rights Act, Interior and Border Enforcement, Unaccompanied Minors, Every Child Achieves Act of 2015, End Racial Profiling Act (ERPA), June 2003 Guidance Regarding the Use of Race by Federal Law Enforcement Agencies, My Brothers Keeper Initiative, DHS Immigration Enforcement Reform: Secure Communities, Priority Enforcement Program (PEP), Detainers, Sanctuary Cities, Family Detention, Immigration Detention, Treatment of Refugee Women and Children/Victims of Violence, FY 2016 National Defense Authorization Act, Targeted Killing, Guantanamo Bay, Indefinite Detention, Sentencing Reform, Private Prisons and Solitary Confinement, Rescission of the OLC Memo, Stonewall National Monument, 1557 Proposed Rule, Gender Biased Policing, Ban the Box Executive Order for Criminal Background Checks in Employment, EO 12333.

Client expense: $337,134 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Bureau of Justice Statistics, Bureau of Prisons (BOP), Bureau of the Census, Defense, Dept of (DOD), Director of National Intelligence (ODNI), Education, Dept of, Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Indian Health Service, Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Oceanic & Atmospheric Administration (NOAA), Natl Security Agency (NSA), Office of Justice Program, Office of Juvenile Justice & Delinquency Prevention, Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Fish & Wildlife Service (USFWS), U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR), Vice President of the U.S., White House Office